News
Empowering the biopharma industry with field-leading foundation models.
Recent News
Press
|
December 2, 2025
Genesis Molecular AI Appoints Sergey Edunov as Senior Vice President of Foundation Models, Further Strengthening Leadership in Machine Learning
Business WIre
Blog
|
October 28, 2025
Introducing Pearl: The Next Generation Foundation Model for Drug Discovery
Press
|
October 28, 2025
Genesis Molecular AI Unveils Pearl
Business Wire
Press
|
October 28, 2025
Genesis says its new AI model bests AlphaFold 3
Endpoints News
Presentations & Publications
|
October 21, 2025
Triangle Multiplication Is All You Need For Biomolecular Structure Representations
arXIV
Press
|
February 20, 2025
Incyte and Genesis Therapeutics Announce Strategic AI-focused Research Collaboration
Incyte
Press
|
December 11, 2024
Genesis Therapeutics Expands Leadership Team with Appointments of Chief Scientific Officer, SVP of Engineering, and Board Chairman
Business Wire
Presentations & Publications
|
November 20, 2024
Boltz-1: Democratizing Biomolecular Interaction Modeling
bioRxiv
Join Us
Opportunities in AI and Physics Research
Our molecular AI research team is pioneering new frameworks for drug discovery, at the intersection of multi-dimensional ML models and physical simulation. See opportunities in software engineering, machine learning and computation chemistry.
Software Engineering
Machine Learning
Computational Chemistry
